Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Johnson & Johnson wins FDA nod for new robotic bronchoscopy software

17 August 2026 · By · Wire by Fusion42

Published

17 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at massdevice.com →

◆ Verified

Fusion42 · 17 August 2026 · Fusion42 review

Johnson & Johnson MedTech received FDA 510(k) clearance for Monarch Quest 3, an upgraded software for its robotic bronchoscopy platform that enhances AI-powered nodule segmentation, imaging compatibility, and procedural precision for lung cancer diagnosis.

This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 17 Aug 2026 and 18 Aug 2026.

◆ ◆ The Wire takeaway

You face rising competition in robot-assisted lung procedures as Johnson & Johnson expands AI and imaging integration, requiring sharper focus on differentiation or partnership in bronchoscopy software development.

◆ Coverage

4 sources · first reported 17 Aug 2026 · latest 18 Aug 2026

◆ Related on Wire

◆ Topics

MedtechroboticsbronchoscopyFDA-clearanceAI-poweredlung-cancer